AAD: Baricitinib Tops Placebo for Hair Regrowth in Alopecia Areata

MONDAY, March 28, 2022 -- For adults with severe alopecia areata, oral baricitinib is superior to placebo with respect to hair regrowth at 36 weeks, according to a study published online March 26 in the New England Journal of Medicine to coincide...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news